Anthropometric and Hormonal Risk Factors for Male Breast Cancer: Male Breast Cancer Pooling Project Results
The etiology of male breast cancer is poorly understood, partly because of its relative rarity. Although genetic factors are involved, less is known regarding the role of anthropometric and hormonally related risk factors. In the Male Breast Cancer Pooling Project, a consortium of 11 case-control an...
Saved in:
Published in | JNCI : Journal of the National Cancer Institute Vol. 106; no. 3; p. djt465 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Cary, NC
Oxford University Press
2014
|
Subjects | |
Online Access | Get full text |
ISSN | 0027-8874 1460-2105 1460-2105 |
DOI | 10.1093/jnci/djt465 |
Cover
Loading…
Abstract | The etiology of male breast cancer is poorly understood, partly because of its relative rarity. Although genetic factors are involved, less is known regarding the role of anthropometric and hormonally related risk factors.
In the Male Breast Cancer Pooling Project, a consortium of 11 case-control and 10 cohort investigations involving 2405 case patients (n = 1190 from case-control and n = 1215 from cohort studies) and 52013 control subjects, individual participant data were harmonized and pooled. Unconditional logistic regression generated study design-specific (case-control/cohort) odds ratios (ORs) and 95% confidence intervals (CIs), with exposure estimates combined using fixed effects meta-analysis. All statistical tests were two-sided.
Risk was statistically significantly associated with weight (highest/lowest tertile: OR = 1.36; 95% CI = 1.18 to 1.57), height (OR = 1.18; 95% CI = 1.01 to 1.38), and body mass index (BMI; OR = 1.30; 95% CI = 1.12 to 1.51), with evidence that recent rather than distant BMI was the strongest predictor. Klinefelter syndrome (OR = 24.7; 95% CI = 8.94 to 68.4) and gynecomastia (OR = 9.78; 95% CI = 7.52 to 12.7) were also statistically significantly associated with risk, relations that were independent of BMI. Diabetes also emerged as an independent risk factor (OR = 1.19; 95% CI = 1.04 to 1.37). There were also suggestive relations with cryptorchidism (OR = 2.18; 95% CI = 0.96 to 4.94) and orchitis (OR = 1.43; 95% CI = 1.02 to 1.99). Although age at onset of puberty and histories of infertility were unrelated to risk, never having had children was statistically significantly related (OR = 1.29; 95% CI = 1.01 to 1.66). Among individuals diagnosed at older ages, a history of fractures was statistically significantly related (OR = 1.41; 95% CI = 1.07 to 1.86).
Consistent findings across case-control and cohort investigations, complemented by pooled analyses, indicated important roles for anthropometric and hormonal risk factors in the etiology of male breast cancer. Further investigation should focus on potential roles of endogenous hormones. |
---|---|
AbstractList | The etiology of male breast cancer is poorly understood, partly because of its relative rarity. Although genetic factors are involved, less is known regarding the role of anthropometric and hormonally related risk factors.
In the Male Breast Cancer Pooling Project, a consortium of 11 case-control and 10 cohort investigations involving 2405 case patients (n = 1190 from case-control and n = 1215 from cohort studies) and 52013 control subjects, individual participant data were harmonized and pooled. Unconditional logistic regression generated study design-specific (case-control/cohort) odds ratios (ORs) and 95% confidence intervals (CIs), with exposure estimates combined using fixed effects meta-analysis. All statistical tests were two-sided.
Risk was statistically significantly associated with weight (highest/lowest tertile: OR = 1.36; 95% CI = 1.18 to 1.57), height (OR = 1.18; 95% CI = 1.01 to 1.38), and body mass index (BMI; OR = 1.30; 95% CI = 1.12 to 1.51), with evidence that recent rather than distant BMI was the strongest predictor. Klinefelter syndrome (OR = 24.7; 95% CI = 8.94 to 68.4) and gynecomastia (OR = 9.78; 95% CI = 7.52 to 12.7) were also statistically significantly associated with risk, relations that were independent of BMI. Diabetes also emerged as an independent risk factor (OR = 1.19; 95% CI = 1.04 to 1.37). There were also suggestive relations with cryptorchidism (OR = 2.18; 95% CI = 0.96 to 4.94) and orchitis (OR = 1.43; 95% CI = 1.02 to 1.99). Although age at onset of puberty and histories of infertility were unrelated to risk, never having had children was statistically significantly related (OR = 1.29; 95% CI = 1.01 to 1.66). Among individuals diagnosed at older ages, a history of fractures was statistically significantly related (OR = 1.41; 95% CI = 1.07 to 1.86).
Consistent findings across case-control and cohort investigations, complemented by pooled analyses, indicated important roles for anthropometric and hormonal risk factors in the etiology of male breast cancer. Further investigation should focus on potential roles of endogenous hormones. The etiology of male breast cancer is poorly understood, partly because of its relative rarity. Although genetic factors are involved, less is known regarding the role of anthropometric and hormonally related risk factors. The etiology of male breast cancer is poorly understood, partly because of its relative rarity. Although genetic factors are involved, less is known regarding the role of anthropometric and hormonally related risk factors.BACKGROUNDThe etiology of male breast cancer is poorly understood, partly because of its relative rarity. Although genetic factors are involved, less is known regarding the role of anthropometric and hormonally related risk factors.In the Male Breast Cancer Pooling Project, a consortium of 11 case-control and 10 cohort investigations involving 2405 case patients (n = 1190 from case-control and n = 1215 from cohort studies) and 52013 control subjects, individual participant data were harmonized and pooled. Unconditional logistic regression generated study design-specific (case-control/cohort) odds ratios (ORs) and 95% confidence intervals (CIs), with exposure estimates combined using fixed effects meta-analysis. All statistical tests were two-sided.METHODSIn the Male Breast Cancer Pooling Project, a consortium of 11 case-control and 10 cohort investigations involving 2405 case patients (n = 1190 from case-control and n = 1215 from cohort studies) and 52013 control subjects, individual participant data were harmonized and pooled. Unconditional logistic regression generated study design-specific (case-control/cohort) odds ratios (ORs) and 95% confidence intervals (CIs), with exposure estimates combined using fixed effects meta-analysis. All statistical tests were two-sided.Risk was statistically significantly associated with weight (highest/lowest tertile: OR = 1.36; 95% CI = 1.18 to 1.57), height (OR = 1.18; 95% CI = 1.01 to 1.38), and body mass index (BMI; OR = 1.30; 95% CI = 1.12 to 1.51), with evidence that recent rather than distant BMI was the strongest predictor. Klinefelter syndrome (OR = 24.7; 95% CI = 8.94 to 68.4) and gynecomastia (OR = 9.78; 95% CI = 7.52 to 12.7) were also statistically significantly associated with risk, relations that were independent of BMI. Diabetes also emerged as an independent risk factor (OR = 1.19; 95% CI = 1.04 to 1.37). There were also suggestive relations with cryptorchidism (OR = 2.18; 95% CI = 0.96 to 4.94) and orchitis (OR = 1.43; 95% CI = 1.02 to 1.99). Although age at onset of puberty and histories of infertility were unrelated to risk, never having had children was statistically significantly related (OR = 1.29; 95% CI = 1.01 to 1.66). Among individuals diagnosed at older ages, a history of fractures was statistically significantly related (OR = 1.41; 95% CI = 1.07 to 1.86).RESULTSRisk was statistically significantly associated with weight (highest/lowest tertile: OR = 1.36; 95% CI = 1.18 to 1.57), height (OR = 1.18; 95% CI = 1.01 to 1.38), and body mass index (BMI; OR = 1.30; 95% CI = 1.12 to 1.51), with evidence that recent rather than distant BMI was the strongest predictor. Klinefelter syndrome (OR = 24.7; 95% CI = 8.94 to 68.4) and gynecomastia (OR = 9.78; 95% CI = 7.52 to 12.7) were also statistically significantly associated with risk, relations that were independent of BMI. Diabetes also emerged as an independent risk factor (OR = 1.19; 95% CI = 1.04 to 1.37). There were also suggestive relations with cryptorchidism (OR = 2.18; 95% CI = 0.96 to 4.94) and orchitis (OR = 1.43; 95% CI = 1.02 to 1.99). Although age at onset of puberty and histories of infertility were unrelated to risk, never having had children was statistically significantly related (OR = 1.29; 95% CI = 1.01 to 1.66). Among individuals diagnosed at older ages, a history of fractures was statistically significantly related (OR = 1.41; 95% CI = 1.07 to 1.86).Consistent findings across case-control and cohort investigations, complemented by pooled analyses, indicated important roles for anthropometric and hormonal risk factors in the etiology of male breast cancer. Further investigation should focus on potential roles of endogenous hormones.CONCLUSIONSConsistent findings across case-control and cohort investigations, complemented by pooled analyses, indicated important roles for anthropometric and hormonal risk factors in the etiology of male breast cancer. Further investigation should focus on potential roles of endogenous hormones. |
Author | Gaziano, J. M. Van Den Eeden, S. K. Johnson, K. C. Pike, M. C. van den Brandt, P. A. Ursin, G. Ewertz, M. Falk, R. T. Isaacs, C. Negri, E. Gkiokas, G. Hollenbeck, A. Parisi, D. Cooke, R. Hsing, A. W. Willett, W. C. Casagrande, J. T. Kolonel, L. N. Michels, K. B. Riboli, E. Sesso, H. D. Weiderpass, E. Gapstur, S. M. Trichopoulos, D. Snyder, K. Thomas, D. B. Henderson, B. E. Petridou, E. T. Swerdlow, A. J. Gaudet, M. M. Cook, M. B. McCormack, V. Brinton, L. A. Lubin, J. H. Guenel, P. Olsson, H. |
Author_xml | – sequence: 1 givenname: L. A. surname: Brinton fullname: Brinton, L. A. – sequence: 2 givenname: M. B. surname: Cook fullname: Cook, M. B. – sequence: 3 givenname: V. surname: McCormack fullname: McCormack, V. – sequence: 4 givenname: K. C. surname: Johnson fullname: Johnson, K. C. – sequence: 5 givenname: H. surname: Olsson fullname: Olsson, H. – sequence: 6 givenname: J. T. surname: Casagrande fullname: Casagrande, J. T. – sequence: 7 givenname: R. surname: Cooke fullname: Cooke, R. – sequence: 8 givenname: R. T. surname: Falk fullname: Falk, R. T. – sequence: 9 givenname: S. M. surname: Gapstur fullname: Gapstur, S. M. – sequence: 10 givenname: M. M. surname: Gaudet fullname: Gaudet, M. M. – sequence: 11 givenname: J. M. surname: Gaziano fullname: Gaziano, J. M. – sequence: 12 givenname: G. surname: Gkiokas fullname: Gkiokas, G. – sequence: 13 givenname: P. surname: Guenel fullname: Guenel, P. – sequence: 14 givenname: B. E. surname: Henderson fullname: Henderson, B. E. – sequence: 15 givenname: A. surname: Hollenbeck fullname: Hollenbeck, A. – sequence: 16 givenname: A. W. surname: Hsing fullname: Hsing, A. W. – sequence: 17 givenname: L. N. surname: Kolonel fullname: Kolonel, L. N. – sequence: 18 givenname: C. surname: Isaacs fullname: Isaacs, C. – sequence: 19 givenname: J. H. surname: Lubin fullname: Lubin, J. H. – sequence: 20 givenname: K. B. surname: Michels fullname: Michels, K. B. – sequence: 21 givenname: E. surname: Negri fullname: Negri, E. – sequence: 22 givenname: D. surname: Parisi fullname: Parisi, D. – sequence: 23 givenname: E. T. surname: Petridou fullname: Petridou, E. T. – sequence: 24 givenname: M. C. surname: Pike fullname: Pike, M. C. – sequence: 25 givenname: E. surname: Riboli fullname: Riboli, E. – sequence: 26 givenname: H. D. surname: Sesso fullname: Sesso, H. D. – sequence: 27 givenname: K. surname: Snyder fullname: Snyder, K. – sequence: 28 givenname: A. J. surname: Swerdlow fullname: Swerdlow, A. J. – sequence: 29 givenname: D. surname: Trichopoulos fullname: Trichopoulos, D. – sequence: 30 givenname: G. surname: Ursin fullname: Ursin, G. – sequence: 31 givenname: P. A. surname: van den Brandt fullname: van den Brandt, P. A. – sequence: 32 givenname: S. K. surname: Van Den Eeden fullname: Van Den Eeden, S. K. – sequence: 33 givenname: E. surname: Weiderpass fullname: Weiderpass, E. – sequence: 34 givenname: W. C. surname: Willett fullname: Willett, W. C. – sequence: 35 givenname: M. surname: Ewertz fullname: Ewertz, M. – sequence: 36 givenname: D. B. surname: Thomas fullname: Thomas, D. B. |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28402951$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/24552677$$D View this record in MEDLINE/PubMed https://lup.lub.lu.se/record/4334393$$DView record from Swedish Publication Index oai:portal.research.lu.se:publications/3cc815b0-36cb-4971-a113-b122937cc040$$DView record from Swedish Publication Index http://kipublications.ki.se/Default.aspx?queryparsed=id:128749488$$DView record from Swedish Publication Index |
BookMark | eNqNkt1rFDEUxYNU7Hb1yXeZF0GQsfmeGR-EulgrrFiKPodM5m43u9lkTTKK_71Zd61WWjAQEu795ZwknBN05IMHhJ4S_Irgjp2uvLGnwypzKR6gCeES15RgcYQmGNOmbtuGH6OTlFa4jI7yR-iYciGobJoJWp_5vIxhGzaQozWV9kN1EeImeO2qK5vW1bk2OcRULUKsPmoH1dsIOuVqpr2B-PqOWnUZgrP-urqMYQUmV1eQRpfTY_RwoV2CJ4d1ir6cv_s8u6jnn95_mJ3NayNxm2vOARZUS4mFIVK0UnLGoe2HjgomgMqWDBgz0pY-GBBMDpprzWTPG6q7nk1RvddN32E79mob7UbHHypoqw6lddmBEpSJojRF-l5-G2LWTkVIoKNZKjfuDhbKWaOzDT4pZkxLRI8Vk6ZXvGuI0oQw1RNKO9YYg_nOY36vhxu3ZfYH7f-Ue7OXK1obGAz4HMs1b938VsfbpboO3xTrGkGkLAIvDgIxfB0hZbWxyYBz2kMYkyKieHactk1Bn_3tdWPyO0QFeH4AdDLaLWJJgU1_uJZj2glSuJd7zsSQUoTFDUKw2kVZ7aKs9lEuNPmHNjb_-vLyIOvuPPMTTXH50g |
CitedBy_id | crossref_primary_10_22141_2224_0721_17_1_2021_226434 crossref_primary_10_1007_s15015_018_3742_3 crossref_primary_10_2217_bmt_2019_0020 crossref_primary_10_1016_j_semcancer_2023_05_002 crossref_primary_10_1016_j_humpath_2015_08_008 crossref_primary_10_1097_CEJ_0000000000000651 crossref_primary_10_1038_srep35121 crossref_primary_10_1186_s12940_015_0061_4 crossref_primary_10_1016_j_clbc_2024_03_014 crossref_primary_10_3233_BD_201024 crossref_primary_10_1210_endrev_bnz001 crossref_primary_10_1093_ajcp_aqw207 crossref_primary_10_33808_clinexphealthsci_910209 crossref_primary_10_1158_1055_9965_EPI_14_1009 crossref_primary_10_12677_acm_2024_1472054 crossref_primary_10_1016_j_endinu_2022_02_003 crossref_primary_10_1111_obr_12705 crossref_primary_10_1016_j_breastdis_2015_04_030 crossref_primary_10_1056_NEJMra1707939 crossref_primary_10_3233_BD_210001 crossref_primary_10_1007_s12609_017_0243_x crossref_primary_10_1245_s10434_018_6767_0 crossref_primary_10_1177_2050313X18781727 crossref_primary_10_1007_s40134_017_0197_9 crossref_primary_10_1016_S2213_8587_15_00474_X crossref_primary_10_1007_s00092_018_1990_3 crossref_primary_10_1016_j_obpill_2024_100106 crossref_primary_10_1002_pds_4947 crossref_primary_10_3390_cancers14133175 crossref_primary_10_14423_SMJ_0000000000001425 crossref_primary_10_1186_s13058_022_01517_z crossref_primary_10_3390_cancers16030579 crossref_primary_10_1038_s41568_020_0266_x crossref_primary_10_1186_s12916_015_0380_x crossref_primary_10_18632_oncotarget_9668 crossref_primary_10_1016_j_breast_2019_09_004 crossref_primary_10_1016_j_ijscr_2019_02_028 crossref_primary_10_18632_oncotarget_12272 crossref_primary_10_1007_s15013_018_1393_2 crossref_primary_10_1007_s10549_014_3087_3 crossref_primary_10_1158_1055_9965_EPI_15_0588 crossref_primary_10_1590_s1677_5538_ibju_2017_0531 crossref_primary_10_1007_s10549_014_3193_2 crossref_primary_10_1016_j_annonc_2022_10_004 crossref_primary_10_1016_j_critrevonc_2016_02_017 crossref_primary_10_1016_j_ctrc_2016_03_004 crossref_primary_10_1148_rg_2018180013 crossref_primary_10_1186_s12885_016_2414_y crossref_primary_10_32074_1591_951X_936 crossref_primary_10_3390_ijms241713053 crossref_primary_10_1056_NEJMsr1606602 crossref_primary_10_1093_jncics_pkab078 crossref_primary_10_1016_j_ejim_2015_11_024 crossref_primary_10_1007_s11912_023_01489_z crossref_primary_10_3109_0284186X_2015_1115118 crossref_primary_10_3389_fonc_2018_00583 crossref_primary_10_3390_cancers15112929 crossref_primary_10_1007_s11154_016_9337_4 crossref_primary_10_18231_j_ijpo_2021_003 crossref_primary_10_3390_jcm14010158 crossref_primary_10_1055_a_1305_0115 crossref_primary_10_3390_ijms241814348 crossref_primary_10_1002_ijc_33938 crossref_primary_10_1055_a_1924_3194 crossref_primary_10_1093_jncics_pkz091 crossref_primary_10_1200_JCO_2014_59_1602 crossref_primary_10_37310_ref_v92i1_2929 crossref_primary_10_1016_j_bjps_2021_03_098 crossref_primary_10_1016_j_senol_2020_11_006 crossref_primary_10_1016_j_canlet_2015_07_040 crossref_primary_10_1097_PRS_0000000000008815 crossref_primary_10_1016_j_critrevonc_2025_104651 crossref_primary_10_1177_2397847319849648 crossref_primary_10_1093_aje_kwad153 crossref_primary_10_1177_15579883221074818 crossref_primary_10_1667_RR15015_1 crossref_primary_10_1016_j_clbc_2014_12_010 crossref_primary_10_1530_EJE_16_0643 crossref_primary_10_18632_oncotarget_24856 crossref_primary_10_1016_j_jss_2020_06_022 crossref_primary_10_1055_a_2080_9617 crossref_primary_10_1002_cam4_1273 crossref_primary_10_1007_s15006_017_0395_7 crossref_primary_10_1016_j_mrfmmm_2017_03_007 crossref_primary_10_1016_j_ogc_2023_11_001 crossref_primary_10_3390_pharmaceutics12050402 crossref_primary_10_1007_s15012_017_2521_8 crossref_primary_10_1016_j_clbc_2015_01_007 crossref_primary_10_1016_j_ejso_2022_06_004 crossref_primary_10_1002_ijc_31121 crossref_primary_10_1155_2016_8264140 crossref_primary_10_1186_s13058_021_01485_w crossref_primary_10_4103_sujhs_sujhs_65_23 crossref_primary_10_14216_kjco_17007 crossref_primary_10_1016_j_semcancer_2023_08_001 crossref_primary_10_1158_1078_0432_CCR_16_2552 crossref_primary_10_1007_s11912_015_0487_4 crossref_primary_10_18632_oncotarget_19132 crossref_primary_10_1002_ijc_32106 crossref_primary_10_1177_1557988319847856 crossref_primary_10_1016_j_endien_2022_02_024 crossref_primary_10_1097_COC_0000000000000943 crossref_primary_10_1007_s15004_020_7991_x crossref_primary_10_1056_NEJMcpc1503831 crossref_primary_10_1093_jncics_pkab079 crossref_primary_10_1056_NEJMc1809194 crossref_primary_10_1016_j_senol_2020_01_003 crossref_primary_10_7717_peerj_7837 crossref_primary_10_1038_nrc3806 |
Cites_doi | 10.1111/j.1572-0241.1998.00231.x 10.1093/ajcn/45.1.277 10.1016/j.steroids.2011.02.029 10.1023/B:CACO.0000036154.18162.43 10.1093/jnci/djn329 10.1093/oxfordjournals.aje.a009786 10.1002/cncr.20797 10.1634/theoncologist.10-7-471 10.3322/caac.21166 10.1002/ijc.2910450415 10.1007/s10549-009-0379-0 10.1001/archinte.167.19.2091 10.1007/s10552-011-9790-z 10.1079/PHN2002394 10.1002/ijc.2910530403 10.1002/ijc.22814 10.1111/j.1651-2227.2010.02131.x 10.1158/1055-9965.20.14.1 10.1016/0021-9681(70)90109-8 10.1093/aje/kwj127 10.1097/MOU.0b013e32831367c7 10.1111/j.1445-2197.2005.03572.x 10.1016/0895-4356(90)90009-E 10.1016/S0197-2456(02)00235-0 10.1093/jnci/dji240 10.1177/0145721708327143 10.1038/bjc.1995.264 10.1093/oxfordjournals.aje.a116360 10.1080/028418601750288181 10.1007/s10552-005-5384-y 10.1093/jnci/74.2.371 10.1002/cncr.27905 10.1016/j.bbalip.2009.06.006 10.1002/(SICI)1097-0142(19990201)85:3<629::AID-CNCR13>3.0.CO;2-V 10.1038/sj.ijo.0803465 10.1093/aje/153.11.1071 10.1023/A:1008869003012 10.1054/bjoc.2000.1467 10.1002/cncr.10197 10.1023/B:BREA.0000010701.08825.2d 10.1245/ASO.2004.01.001 10.1038/bjc.2012.577 10.1093/oxfordjournals.aje.a010213 10.1136/oem.2009.052175 10.1093/jnci/80.9.679 10.1016/0091-7435(73)90064-9 10.1097/00008469-200206000-00009 10.1093/jnci/djg009 |
ContentType | Journal Article |
Copyright | 2015 INIST-CNRS Published by Oxford University Press 2014. 2014 |
Copyright_xml | – notice: 2015 INIST-CNRS – notice: Published by Oxford University Press 2014. 2014 |
CorporateAuthor | The European Rare Cancer Study Group European Rare Cancer Study Group Institutionen för kliniska vetenskaper, Lund Lunds universitet Profile areas and other strong research environments Lund University Breastcancer-genetics Department of Clinical Sciences, Lund Section I Strategiska forskningsområden (SFO) EpiHealth: Epidemiology for Health Faculty of Medicine Bröstcancer-genetik Strategic research areas (SRA) Sektion I Medicinska fakulteten Profilområden och andra starka forskningsmiljöer |
CorporateAuthor_xml | – name: The European Rare Cancer Study Group – name: European Rare Cancer Study Group – name: Faculty of Medicine – name: Medicinska fakulteten – name: Strategiska forskningsområden (SFO) – name: Bröstcancer-genetik – name: EpiHealth: Epidemiology for Health – name: Institutionen för kliniska vetenskaper, Lund – name: Section I – name: Strategic research areas (SRA) – name: Lunds universitet – name: Sektion I – name: Department of Clinical Sciences, Lund – name: Profilområden och andra starka forskningsmiljöer – name: Lund University – name: Profile areas and other strong research environments – name: Breastcancer-genetics |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 5PM ADTPV AOWAS D95 |
DOI | 10.1093/jnci/djt465 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) SwePub SwePub Articles SWEPUB Lunds universitet |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1460-2105 |
EndPage | djt465 |
ExternalDocumentID | oai_swepub_ki_se_523500 oai_portal_research_lu_se_publications_3cc815b0_36cb_4971_a113_b122937cc040 oai_lup_lub_lu_se_3cc815b0_36cb_4971_a113_b122937cc040 PMC3975166 24552677 28402951 10_1093_jnci_djt465 |
Genre | Meta-Analysis Journal Article Research Support, N.I.H., Intramural |
GrantInformation_xml | – fundername: Intramural NIH HHS – fundername: European Research Council grantid: 294576 |
GroupedDBID | --- -E4 -~X .2P .I3 .XZ .ZR 08P 0R~ 1TH 29L 2WC 354 4.4 482 48X 53G 5GY 5RE 5VS 5WD 70D 96U AABZA AACZT AAHTB AAJKP AAJQQ AAKAS AAMVS AAOGV AAPNW AAPQZ AAPXW AARHZ AAUAY AAUQX AAVAP AAWTL AAYXX ABCQX ABDFA ABEJV ABEUO ABGNP ABIXL ABJNI ABKDP ABNHQ ABNKS ABOCM ABPEJ ABPMR ABPPZ ABPTD ABQLI ABQNK ABVGC ABXVV ABZBJ ACBMB ACGFO ACGFS ACGOD ACKOT ACNCT ACPRK ACUFI ACUTJ ACUTO ACYHN ADBBV ADEYI ADEZT ADGZP ADHKW ADHZD ADIPN ADNBA ADOCK ADQBN ADRTK ADVEK ADYVW ADZCM AEGPL AEJOX AEKSI AEMDU AEMQT AENZO AEPUE AETBJ AEWNT AFAZI AFCHL AFFNX AFFZL AFIYH AFOFC AFRAH AFXAL AFYAG AGINJ AGKEF AGORE AGSYK AGUTN AHMBA AHMMS AHXPO AIAGR AIJHB AJBYB AJEEA AJNCP ALMA_UNASSIGNED_HOLDINGS ALUQC ALXQX APIBT APWMN ATGXG BAWUL BAYMD BCRHZ BEYMZ BTRTY BVRKM C45 CDBKE CITATION CS3 CZ4 DAKXR DIK DILTD DU5 D~K E3Z EBS EE~ EJD EMOBN ENERS F5P F8P F9B FECEO FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC GX1 H13 H5~ HAR HW0 HZ~ IH2 IOX J21 JXSIZ KAQDR KBUDW KOP KQ8 KSI KSN L7B M-Z MHKGH ML0 N9A NGC NOMLY NOYVH NU- NVLIB OAUYM OAWHX OBH OCB OCZFY ODMLO ODZKP OGEVE OHH OJQWA OJZSN OK1 OPAEJ OVD OWPYF P2P PAFKI PEELM PQQKQ Q.- Q1. Q5Y R44 RD5 RNS ROL ROX ROZ RUSNO RW1 RXO TCURE TEORI TJX TMA TR2 TWZ UDS UPT VVN W8F WH7 WOQ X7H YAYTL YKOAZ YQT YXANX ZKX ZRR ZY1 ~91 ~H1 -DD .55 .GJ 186 2QL 3O- 8WZ A6W AAGKA AAPGJ AAQQT AAWDT ABEFU ABNGD ABQTQ ABSMQ ACFRR ACPQN ACUKT ACVCV ACZBC ADMTO AEHUL AEKPW AETEA AFFQV AFSHK AGKRT AGMDO AGNAY AI. AJDVS APJGH AQDSO AQKUS ASPBG ATTQO AVNTJ AVWKF AZFZN BKOMP BZKNY CAG COF EIHJH FA8 FEDTE GOZPB GRPMH HVGLF IQODW J5H LXL LXN LXY M49 MBLQV MVM NTWIH O0~ OBFPC O~Y PB- QBD RNI RZF RZO VH1 X7M XJT Y6R YHZ YR5 ~X8 ADXHL AGQPQ AHGBF CGR CUY CVF ECM EIF NPM 7X8 5PM ADTPV AOWAS D95 |
ID | FETCH-LOGICAL-c608t-44eef2a6605c165866434e8bd92535e2681d0031805cece536da4aa36b472a9b3 |
ISSN | 0027-8874 1460-2105 |
IngestDate | Mon Sep 01 03:33:25 EDT 2025 Wed Aug 27 04:00:19 EDT 2025 Thu Jul 03 05:11:58 EDT 2025 Thu Aug 21 13:52:15 EDT 2025 Fri Jul 11 15:39:01 EDT 2025 Mon Jul 21 05:53:13 EDT 2025 Wed Apr 02 07:37:53 EDT 2025 Thu Apr 24 23:07:03 EDT 2025 Tue Jul 01 01:42:19 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Mammary gland diseases Breast disease Cancerology Anthropometry Risk factor Male Breast cancer Malignant tumor Epidemiology Cancer |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c608t-44eef2a6605c165866434e8bd92535e2681d0031805cece536da4aa36b472a9b3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://academic.oup.com/jnci/article-pdf/106/3/djt465/7677932/djt465.pdf |
PMID | 24552677 |
PQID | 1511394287 |
PQPubID | 23479 |
ParticipantIDs | swepub_primary_oai_swepub_ki_se_523500 swepub_primary_oai_portal_research_lu_se_publications_3cc815b0_36cb_4971_a113_b122937cc040 swepub_primary_oai_lup_lub_lu_se_3cc815b0_36cb_4971_a113_b122937cc040 pubmedcentral_primary_oai_pubmedcentral_nih_gov_3975166 proquest_miscellaneous_1511394287 pubmed_primary_24552677 pascalfrancis_primary_28402951 crossref_primary_10_1093_jnci_djt465 crossref_citationtrail_10_1093_jnci_djt465 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2014 |
PublicationDateYYYYMMDD | 2014-01-01 |
PublicationDate_xml | – year: 2014 text: 2014 |
PublicationDecade | 2010 |
PublicationPlace | Cary, NC |
PublicationPlace_xml | – name: Cary, NC – name: United States – name: US |
PublicationTitle | JNCI : Journal of the National Cancer Institute |
PublicationTitleAlternate | J Natl Cancer Inst |
PublicationYear | 2014 |
Publisher | Oxford University Press |
Publisher_xml | – name: Oxford University Press |
References | (52_43839904) 2007; 31 Brinton (20_34487098) 2010; 119 D'Avanzo (8_15903833) 1995; 71 (38_21953711) 2006; 163 Petridou (27_10508475) 2000; 83 Sasco (47_10144530) 1993; 53 Thomas (16_9849935) 1992; 135 Kolonel (32_6487781) 2000; 151 Siiteri (41_14027329) 1987; 45 Johnson (12_17155374) 2002; 11 (7_32078765) 2008; 100 Brinton (14_39063979) 2011; 100 Lenfant-Pejovic (17_5602565) 1990; 45 Anderson (2_18066631) 2004; 83 Hultborn (21_5913687) 1997; 17 Newcomb (50_11181225) 2001; 153 Travis (44_29163094) 2007; 121 S rensen (18_5887396) 1998; 93 Rice (48_34686512) 2008; 34 Sesso (35_17388344) 2002; 23 Ahn (13_29622112) 2007; 167 (24_47449954) 2013; 108 Riboli (34_17423850) 2002; 5 (53_47449955) 2013; 119 (1_45300013) 2013; 63 Hsing (11_6096032) 1998; 9 Ewertz (9_11278545) 2001; 40 van den Brandt (36_5575569) 1990; 43 Gu nel (10_18274805) 2004; 15 Goodman (3_21464376) 2006; 17 Modan (23_11594984) 1970; 23 (28_37936531) 2010; 67 Swerdlow (39_19333466) 2005; 97 de Bree (45_19424734) 2005; 75 Calle (29_16962543) 2002; 94 (42_45574109) 2011; 76 Giovannucci (30_17775132) 2003; 95 Rohrmann (43_40157899) 2011; 22 Hennessy (37_10713975) 1999; 149 Hodgson (5_18279955) 2004; 11 (22_42178036) 1985; 74 Giordano (4_19308668) 2005; 10 Wang (49_35266971) 2009; 1791 Casagrande (19_4857379) 1988; 48 Olsson (26_4920994) 1988; 80 Paduch (15_32077289) 2008; 18 Anderson (6_18636169) 2005; 103 Weiss (40_18637329) 2005; 14 Cutler (31_12512882) 1973; 2 Goss (46_10761821) 1999; 85 J Natl Cancer Inst. 2014 May;106(5):dju117 |
References_xml | – volume: 93 start-page: 231 issn: 0002-9270 issue: 2 year: 1998 ident: 18_5887396 publication-title: The American journal of gastroenterology doi: 10.1111/j.1572-0241.1998.00231.x – volume: 45 start-page: 277 issn: 0002-9165 issue: 1 year: 1987 ident: 41_14027329 publication-title: The American Journal of Clinical Nutrition doi: 10.1093/ajcn/45.1.277 – volume: 76 start-page: 812 issn: 0039-128X year: 2011 ident: 42_45574109 publication-title: Steroids doi: 10.1016/j.steroids.2011.02.029 – volume: 15 start-page: 571 issn: 0957-5243 issue: 6 year: 2004 ident: 10_18274805 publication-title: Cancer causes & control : CCC doi: 10.1023/B:CACO.0000036154.18162.43 – volume: 100 start-page: 1477 issn: 0027-8874 issue: 20 year: 2008 ident: 7_32078765 publication-title: JNCI Journal of the National Cancer Institute doi: 10.1093/jnci/djn329 – volume: 149 start-page: 195 issn: 0002-9262 issue: 2 year: 1999 ident: 37_10713975 publication-title: American Journal of Epidemiology doi: 10.1093/oxfordjournals.aje.a009786 – volume: 103 start-page: 432 issn: 0008-543X issue: 2 year: 2005 ident: 6_18636169 publication-title: Cancer doi: 10.1002/cncr.20797 – volume: 10 start-page: 471 issn: 1083-7159 issue: 7 year: 2005 ident: 4_19308668 publication-title: The Oncologist doi: 10.1634/theoncologist.10-7-471 – volume: 63 start-page: 11 issn: 0007-9235 year: 2013 ident: 1_45300013 publication-title: CA: A Cancer Journal for Clinicians doi: 10.3322/caac.21166 – volume: 45 start-page: 661 issn: 0020-7136 issue: 4 year: 1990 ident: 17_5602565 publication-title: International journal of cancer. Journal international du cancer doi: 10.1002/ijc.2910450415 – volume: 119 start-page: 185 issn: 0167-6806 issue: 1 year: 2010 ident: 20_34487098 publication-title: Breast cancer research and treatment doi: 10.1007/s10549-009-0379-0 – volume: 167 start-page: 2091 issn: 0003-9926 issue: 19 year: 2007 ident: 13_29622112 publication-title: Archives of Internal Medicine doi: 10.1001/archinte.167.19.2091 – volume: 22 start-page: 1141 issn: 0957-5243 issue: 8 year: 2011 ident: 43_40157899 publication-title: Cancer causes & control : CCC doi: 10.1007/s10552-011-9790-z – volume: 5 start-page: 1113 issn: 1368-9800 issue: 6B year: 2002 ident: 34_17423850 publication-title: Public health nutrition doi: 10.1079/PHN2002394 – volume: 53 start-page: 538 issn: 0020-7136 issue: 4 year: 1993 ident: 47_10144530 publication-title: International journal of cancer. Journal international du cancer doi: 10.1002/ijc.2910530403 – volume: 121 start-page: 1331 issn: 0020-7136 issue: 6 year: 2007 ident: 44_29163094 publication-title: International journal of cancer. Journal international du cancer doi: 10.1002/ijc.22814 – volume: 100 start-page: 814 issn: 0365-1436 issue: 6 year: 2011 ident: 14_39063979 publication-title: Acta paediatrica (Oslo, Norway : 1992) doi: 10.1111/j.1651-2227.2010.02131.x – volume: 14 start-page: 20 issn: 1055-9965 issue: 1 year: 2005 ident: 40_18637329 publication-title: Cancer Epidemiology Biomarkers & Prevention doi: 10.1158/1055-9965.20.14.1 – volume: 23 start-page: 55 issn: 0021-9681 issue: 1 year: 1970 ident: 23_11594984 publication-title: Journal of chronic diseases doi: 10.1016/0021-9681(70)90109-8 – volume: 163 start-page: 1053 issn: 0002-9262 issue: 11 year: 2006 ident: 38_21953711 publication-title: American Journal of Epidemiology doi: 10.1093/aje/kwj127 – volume: 48 start-page: 1326 issn: 0008-5472 issue: 5 year: 1988 ident: 19_4857379 publication-title: Cancer Research – volume: 18 start-page: 621 issn: 0963-0643 issue: 6 year: 2008 ident: 15_32077289 publication-title: Current opinion in urology doi: 10.1097/MOU.0b013e32831367c7 – volume: 75 start-page: 914 issn: 1445-1433 issue: 10 year: 2005 ident: 45_19424734 publication-title: ANZ journal of surgery doi: 10.1111/j.1445-2197.2005.03572.x – volume: 43 start-page: 285 issn: 0895-4356 issue: 3 year: 1990 ident: 36_5575569 publication-title: Journal of clinical epidemiology doi: 10.1016/0895-4356(90)90009-E – volume: 23 start-page: 686 issn: 0197-2456 issue: 6 year: 2002 ident: 35_17388344 publication-title: Controlled clinical trials doi: 10.1016/S0197-2456(02)00235-0 – volume: 97 start-page: 1204 issn: 0027-8874 issue: 16 year: 2005 ident: 39_19333466 publication-title: JNCI Journal of the National Cancer Institute doi: 10.1093/jnci/dji240 – volume: 34 start-page: 97S issn: 0145-7217 issue: 5_suppl year: 2008 ident: 48_34686512 publication-title: The Diabetes Educator doi: 10.1177/0145721708327143 – volume: 17 start-page: 4293 issn: 0250-7005 issue: 6D year: 1997 ident: 21_5913687 publication-title: Anticancer Research – volume: 71 start-page: 1359 issn: 1532-1827 issue: 6 year: 1995 ident: 8_15903833 publication-title: British Journal of Cancer doi: 10.1038/bjc.1995.264 – volume: 135 start-page: 734 issn: 0002-9262 issue: 7 year: 1992 ident: 16_9849935 publication-title: American Journal of Epidemiology doi: 10.1093/oxfordjournals.aje.a116360 – volume: 40 start-page: 467 issn: 0284-186X issue: 4 year: 2001 ident: 9_11278545 publication-title: Acta oncologica (Stockholm, Sweden) doi: 10.1080/028418601750288181 – volume: 17 start-page: 127 issn: 0957-5243 issue: 2 year: 2006 ident: 3_21464376 publication-title: Cancer causes & control : CCC doi: 10.1007/s10552-005-5384-y – volume: 74 start-page: 371 issn: 0027-8874 issue: 2 year: 1985 ident: 22_42178036 publication-title: JNCI Journal of the National Cancer Institute doi: 10.1093/jnci/74.2.371 – volume: 119 start-page: 1611 issn: 0008-543X year: 2013 ident: 53_47449955 publication-title: Cancer doi: 10.1002/cncr.27905 – volume: 1791 start-page: 1037 issn: 0006-3002 issue: 11 year: 2009 ident: 49_35266971 publication-title: Biochimica et Biophysica Acta. Protein Structure and Molecular Enzymology doi: 10.1016/j.bbalip.2009.06.006 – volume: 85 start-page: 629 issn: 0008-543X issue: 3 year: 1999 ident: 46_10761821 publication-title: Cancer doi: 10.1002/(SICI)1097-0142(19990201)85:3<629::AID-CNCR13>3.0.CO;2-V – volume: 31 start-page: 685 issn: 1476-5497 year: 2007 ident: 52_43839904 doi: 10.1038/sj.ijo.0803465 – volume: 153 start-page: 1071 issn: 0002-9262 issue: 11 year: 2001 ident: 50_11181225 publication-title: American Journal of Epidemiology doi: 10.1093/aje/153.11.1071 – volume: 9 start-page: 269 issn: 0957-5243 issue: 3 year: 1998 ident: 11_6096032 publication-title: Cancer causes & control : CCC doi: 10.1023/A:1008869003012 – volume: 83 start-page: 1234 issn: 1532-1827 issue: 9 year: 2000 ident: 27_10508475 publication-title: British Journal of Cancer doi: 10.1054/bjoc.2000.1467 – volume: 94 start-page: 500 issn: 0008-543X issue: 2 year: 2002 ident: 29_16962543 publication-title: Cancer doi: 10.1002/cncr.10197 – volume: 83 start-page: 77 issn: 0167-6806 issue: 1 year: 2004 ident: 2_18066631 publication-title: Breast cancer research and treatment doi: 10.1023/B:BREA.0000010701.08825.2d – volume: 11 start-page: 751 issn: 1068-9265 issue: 8 year: 2004 ident: 5_18279955 publication-title: Annals of Surgical Oncology doi: 10.1245/ASO.2004.01.001 – volume: 108 start-page: 959 issn: 1532-1827 year: 2013 ident: 24_47449954 publication-title: British Journal of Cancer doi: 10.1038/bjc.2012.577 – volume: 151 start-page: 346 issn: 0002-9262 issue: 4 year: 2000 ident: 32_6487781 publication-title: American Journal of Epidemiology doi: 10.1093/oxfordjournals.aje.a010213 – volume: 67 start-page: 837 issn: 1351-0711 issue: 12 year: 2010 ident: 28_37936531 publication-title: Occupational and Environmental Medicine doi: 10.1136/oem.2009.052175 – volume: 80 start-page: 679 issn: 0027-8874 issue: 9 year: 1988 ident: 26_4920994 publication-title: JNCI Journal of the National Cancer Institute doi: 10.1093/jnci/80.9.679 – volume: 2 start-page: 197 issn: 0091-7435 issue: 2 year: 1973 ident: 31_12512882 publication-title: Preventive medicine doi: 10.1016/0091-7435(73)90064-9 – volume: 11 start-page: 253 issn: 0959-8278 issue: 3 year: 2002 ident: 12_17155374 publication-title: European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) doi: 10.1097/00008469-200206000-00009 – volume: 95 start-page: 1240 issn: 0027-8874 issue: 16 year: 2003 ident: 30_17775132 publication-title: JNCI Journal of the National Cancer Institute doi: 10.1093/jnci/djg009 – reference: - J Natl Cancer Inst. 2014 May;106(5):dju117 |
SSID | ssj0000924 |
Score | 2.4546466 |
SecondaryResourceType | review_article |
Snippet | The etiology of male breast cancer is poorly understood, partly because of its relative rarity. Although genetic factors are involved, less is known regarding... |
SourceID | swepub pubmedcentral proquest pubmed pascalfrancis crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | djt465 |
SubjectTerms | Adult Aged Biological and medical sciences Body Mass Index Breast Neoplasms, Male - etiology Breast Neoplasms, Male - genetics Breast Neoplasms, Male - metabolism Cancer and Oncology Cancer och onkologi Case-Control Studies Clinical Medicine Cohort Studies Epididymitis - complications Gonadal Steroid Hormones - metabolism Gynecology. Andrology. Obstetrics Gynecomastia - complications Humans Klinefelter Syndrome - complications Klinisk medicin Logistic Models Male Mammary gland diseases Medical and Health Sciences Medical sciences Medicin och hälsovetenskap Middle Aged Multiple tumors. Solid tumors. Tumors in childhood (general aspects) Odds Ratio Orchitis - complications Overweight - complications Reproduction Risk Assessment Risk Factors Testis - injuries Tumors |
Title | Anthropometric and Hormonal Risk Factors for Male Breast Cancer: Male Breast Cancer Pooling Project Results |
URI | https://www.ncbi.nlm.nih.gov/pubmed/24552677 https://www.proquest.com/docview/1511394287 https://pubmed.ncbi.nlm.nih.gov/PMC3975166 https://lup.lub.lu.se/record/4334393 oai:portal.research.lu.se:publications/3cc815b0-36cb-4971-a113-b122937cc040 http://kipublications.ki.se/Default.aspx?queryparsed=id:128749488 |
Volume | 106 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBahgzEYY_d6l6JB2cNKWluy5HhvIbRLliUpXQqlL8JXmjazwxK_7K_sz-7oYsdePdbtISZIsmz8ffa56OgchPYDm8Vp7LEu90NpoDDSBTnudNOYpZQSFpBU7h2eTPnw3P18wS46nZ-1qKViEx5GP1r3lfwPqtAGuMpdsv-AbDUpNMB_wBeOgDAc74RxWeXgmyyLpfOuDkEHVc69MxkzfmKq6chYwgmIAoBS1uo5GEisVYHI260Hp3mu9qifaieN9PAXS53wqVJjp4ORcibU9FkVLVm6Fs1UVShCZfWfjabzmQot-JIXC5kVpVoFmc3GtUD-bTnoT_3LUX86U3w7bMT5y87xaDbuf63c-4u84chwti7MP2yNrH-2CYjSni7nU322bV7jJ20VBzpV1nUWSSjj642r61I0027_Jg6rIEUQ3Dbx5fb8ewRsEFUX5GIbP2T7xKT41vdmNn_CJY_kBY_05RrqzsNVsIY3L9UlU9psmtuhuY0EtkrpmT9Gjwy6uK-p9wR1kuwpuj8x8RjP0E2TgRgYiEsGYslAbBiI4dljyTWsuYY1QT62tGHDP2z4hw3_nqPzk-P5YNg15Tu6Ebd7m67rJklKAg4Gc-SAostB-XWTXhj7hFGWEA6mkpIp0J9ECaM8DtwgoDx0PRL4IX2BdrI8S3YRBiVZuTLUsnGUBqFrpzQhNGVu6rMwtdCH8imLyOS2lyVWlkLHWFAhIREaEgvtV4NXOqVL-7C9BlzV2JIXFnpX4ifgmywX2oIsyYu1AC0aDCvpjLDQS43n9myXMcI96PEaSFcDZL73Zk-2uFJ538F0YA7nFjrWnGicsixW8AvhJ9aJoFHUc1hoC8qjULi-54gA7kmEDgH93osikN0WumyZR1v9wqQauzLzrWprCHec_H3L5KbpZiHnZIQy2371t8f8Gj2QXwvt9nyDdjbfi-QtGAKbcE-9kL8AaGAQoQ |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Anthropometric+and+Hormonal+Risk+Factors+for+Male+Breast+Cancer%3A+Male+Breast+Cancer+Pooling+Project+Results&rft.jtitle=JNCI+%3A+Journal+of+the+National+Cancer+Institute&rft.au=BRINTON%2C+Louise+A&rft.au=COOK%2C+Michael+B&rft.au=GAZIANO%2C+J.+Michael&rft.au=GKIOKAS%2C+Georgios&rft.date=2014&rft.pub=Oxford+University+Press&rft.issn=0027-8874&rft.volume=106&rft.issue=3&rft_id=info:doi/10.1093%2Fjnci%2Fdjt465&rft.externalDBID=n%2Fa&rft.externalDocID=28402951 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0027-8874&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0027-8874&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0027-8874&client=summon |